Transcutaneous Aortic Valve Implantation Using the Left Carotid Access: Feasibility and Early Clinical Outcomes

Modine, Thomas; Sudre, Arnaud; Delhaye, Cédric; Fayad, Georges; Lemesle, Gilles; Collet, F; Koussa, Mohamad

doi:10.1016/j.athoracsur.2012.01.030

Cited by 83 publications

(70 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Later, Modine et al further reported successful implantation of a self-expanding valve via transcarotid access, with one transient ischaemic attack (7%) and no vascular access site complications as early outcomes in a series of 12 patients [14]. More recently, Azmoun et al reported no cerebrovascular events or access site complications in a series of 19 patients undergoing TAVI of both self-expanding and balloon-expandable valves via transcarotid access under local anaesthesia [15].…”

Section: Discussionmentioning

confidence: 99%

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes

Kallinikou

Berger

Ruchat

et al. 2017

Archives of Cardiovascular Diseases

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes

Kallinikou

Berger

Ruchat

et al. 2017

Archives of Cardiovascular Diseases

View full text Add to dashboard Cite

“…There were no incidences of clinical stroke, however one study reported a new ischaemic lesion on diffusion weighted-MRI (6). Two transient ischaemic attacks were reported (10,18). 10 patients required a transfusion of at least 2 units of packed red cells (8,15,19).…”

Section: Other Perioperative Outcomesmentioning

confidence: 99%

A systematic review of transcatheter aortic valve implantation via carotid artery access

Stonier

Harrison

Choong

2016

International Journal of Cardiology

View full text Add to dashboard Cite

& Keywords BackgroundThe carotid artery is a novel access route for transcatheter aortic valve implantation (TAVI). This may represent a viable alternative in patients unsuitable for TAVI via traditional transfemoral access, up to 20%, as well as other access routes such as subclavian, transapical and aortic. This systematic review summarises the current evidence for its safety and feasibility. Methods A systematic review was conducted as per the Preferred Reporting Instructions forSystematic Reviews and Meta-analysis (PRISMA) guidelines using five electronic databases. Results16 studies were identified, including three prospective cohort studies, one retrospective cohort study, three case series and eight case reports. Data on 74 patients (mean age 76.9 years) was extracted including pre-operative work-up, technical procedure details and outcomes.This found 1 intraoperative death, 2 further deaths within 30 days, two incidences of transient ischaemic attack, no incidences of stroke, myocardial infarction, carotid A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT3 access site complications or infection, 1 patient required new dialysis and 1 patient had an intraoperative dissection which resolved. Follow-up from 30 days to 1 year showed symptomatic improvement and echocardiographic improvement in line with those seen in transfemoral TAVI. ConclusionsThe available data on TAVI via carotid access demonstrate technical feasibility with comparable outcomes to other traditional access routes. A low number of patients, heterogeneous clinical endpoints and relatively short follow-up periods limit formal meta-analysis and firmer conclusions. For patients in which other access routes are impossible, TAVI via carotid access represents a viable and potentially crucial alternative in patients who might otherwise be untreatable.

show abstract

“…5,6,26,30,56,57 To reduce the risk of vascular complications, alternative access routes have been proposed (ie, the transapical approach, the transaortic, the subclavian, the transaxillary, the transcarotid, and the retroperitoneal access) which can be considered in patients with an unfavorable iliofemoral anatomy. [58][59][60][61][62] In addition, effort has been made to miniaturize the delivery systems and develop valves with a low crossing profile. Recently, Edwards Lifesciences introduced a selfexpandable introducer sheath, namely e-Sheath (initial diameter: 14F-20F) that can temporally expand and facilitate the passage of larger prostheses (Figure 1).…”

Section: Vascular Complicationsmentioning

confidence: 99%

Evolution of Transcatheter Aortic Valve Replacement

Bourantas

Serruys

2014

Circulation Research

View full text Add to dashboard Cite

Transcutaneous Aortic Valve Implantation Using the Left Carotid Access: Feasibility and Early Clinical Outcomes

Cited by 83 publications

References 19 publications

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes

A systematic review of transcatheter aortic valve implantation via carotid artery access

Evolution of Transcatheter Aortic Valve Replacement

Contact Info

Product

Resources

About